
The PEDVAC-iNTS Consortium partecipated in the 12th EDTCP Forum, held from 15 to 20 June 2025 at the Kigali Convention Centre, in Kigali, Rwanda. Under the theme “Better health through global research partnerships,” the Forum provided an international platform to showcase impactful research on poverty-related and neglected infectious diseases in sub-Saharan Africa.
Hosted by the Ministry of Health of Rwanda and the Rwanda Biomedical Centre, and jointly organised by Global Health EDCTP3 and the EDCTP Association, the Forum brought together global health researchers, policymakers, and stakeholders to strengthen capacity and collaboration.

On behalf of the PEDVAC-iNTS Consortium Ashwani Kumar Arora of GSK Vaccines for Global Health (GVGH), Italy, delivered a presentation titled: “Phase 2 trial of the iNTS-GMMA vaccine against invasive nontyphoidal salmonellosis in adults, children, and infants from Africa: study design and initial safety data.” This presentation was featured under the session on Diarrhoeal diseases and antimicrobial resistance, highlighting the Consortium’s progress in developing a novel vaccine to combat invasive Non-Typhoidal Salmonellosis (iNTS)—a major public health concern in sub-Saharan Africa.
The Forum was a valuable opportunity for PEDVAC-iNTS to share ongoing work, exchange knowledge, and strengthen ties with global research partners committed to advancing equitable health solutions.
Additional information on the 13th EDCTP Forum are available here: Forum website, Scientific Fully Programme
Photo courtesy of PEDVAC-iNTS partners attending the 12th EDCTP Forum.